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ORIGINAL CONTRIBUTION
The Measurement of Fatigue in Patients 
With Multiple Sclerosis
A Multidimensional Comparison W ith  Patients  
W ith Chronic Fatigue Syndrome and Healthy Subjects
Jan H. M. M. Vercoulen, Drs; Otto R. Homines, MD; Caroline M. A. Swanink, MD; Peter J. H. Jongen, MD; 
Jan F. M. Fennis, MD; Joep M. D. Galama, MD; Jos \V. M. van der Meer, MD; Gijs Bleijenberg, PhD
O bjective: To provide a multidimensional character­
ization of fatigue in patients with multiple sclerosis (MS).
Design: Cross-sectional design. Fifty patients with clini­
cally definite MS were compared on the dimensions of 
fatigue with 51 patients with chronic fatigue syndrome 
(CFS) and 53 healthy subjects.
Results: Fourty-six percent of the patients with MS reported
%
fatigue to be present at least once a week. Patients with MS 
and patients with CFS had significantly higher subjective 
fatigue severity scores than healthy subjects. Patients with 
MS and patients with CFS had significantly higher scores 
on measures of psychological well-being than healthy sub­
jects. Patients with MS had scores similar to those of patients 
with CFS, except that patients with CFS had significantly 
higher somatization scores. High somatization scores re­
flect strong focusing on bodily sensations. Both groups of 
patients were significantly less active than the healthy sub­
jects. The Kurtzke Expanded Disability Status Scale (EDSS) 
and the Beck Depression Inventory scores were not related 
to subjective fatigue severity. In patients with MS and in pa­
tients with CFS, subjective fatigue severity was related to 
impairment in daily life, low sense of control over symp­
toms, and strong focusing on bodily sensations. In CFS, but 
not in MS, evidence was found for a relationship between 
low levels of physical activity and attributing symptoms to 
a physical cause and between subjective fatigue severity and 
physical activity.
Conclusions: Patients with MS experienced significant 
fatigue, which had a significant impact on daily function­
ing and was not related to depression or Expanded Dis­
ability Status Scale score. Psychological factors, such as 
focusing on bodily sensations and low sense of control, 
play a role in the experience of fatigue in MS and CFS.
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A TIG U E IS f req u en t ly  re ­
ported by patients with mul­
tiple sclerosis (MS). Subjec­
tive fatigue in a patient with 
MS is perceived as different 
from the fatigue experienced when that pa­
tient was still healthy.1'3 In one study, 87% 
of patients with MS reported fatigue to be 
a problem; fatigue was the presenting 
symptom in 33% of the patients; and a 
similar percentage of the patients indi­
cated that fatigue was the most troubling 
symptom .4 In view of the fact that fatigue 
is a frequent symptom in MS, it is surpris­
ing that it has received little attention in 
research. Multiple sclerosis is an inflam­
matory disease of the central nervous sys­
tem. It is therefore reasonable to assume 
that fatigue in MS is related to somatic pro­
cesses, but evidence for this hypothesis is 
lacking. The role of psychological factors 
with respect to fatigue in MS is also u n ­
clear.
This lack of clarity may be attribut­
able in part to the fact that fatigue has been
notoriously difficult to define or m ea­
sure .5 In a study of patients with chronic 
fatigue syndrome (CFS), we found that dif­
ferent dimensions of fatigue could be dis­
cerned: subjective feeling of fatigue, psy­
c h o lo g i c a l  w e l l - b e in g ,  f u n c t i o n a l  
impairment, level of physical activity, sleep 
problems, social functioning, neuropsy­
chological functioning, attributions with 
respect to the causes of complaints, and 
sense of control over sym ptom s (self- 
efficacy expec ta tions) .5 These d im en ­
sions were shown to be relatively inde­
pendent. Thus, each dimension provides 
a unique contribution to the description 
of the patient. Comprehensive assess­
ment of fatigue should therefore entail 
multidimensional assessment. Studies us­
ing only 1 type of questionnaire, such as
See Patients and Methods  
on next page
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PATIENTS A N D  METHODS
PATIENTS
Fifty patients with clinically definite MS12 participated in 
th i s  s t u d y  ( c h r o n i c  p r o g r e s s i v e ,  n = 1 9 ;  r e l a p s i n g -  
rem it t ing ,  n = 31). All p a t ien ts  were  mobile .  The  m ean  
Kurtzke Expanded  Disability Status Scale (EDSS) 13 score 
was 2.8 (range, 1-6). Seventy-five percent of the patients 
had  EDSS scores between 2 and 3.5.
F if ty-one p a t ien ts  w ith  c h ro n ic  sub jec t ive  fatigue 
were random ly selected from our  CFS database, acquired 
by referral to the General In ternal  M edicine o u tpa t ien t  
clinic of the University Hospital Nijmegen, Nijmegen, the 
N etherlands ,  by a family physic ian  or specialist, and  by 
self-referral. These patients had to have experienced dis­
abling fatigue for at least 6 m on ths  for w hich  no somatic 
ex p lan a t io n  cou ld  be offered and  tha t  d id  n o t  subs ide  
with bedres t .H Fifty-three healthy subjects were selected 
through a regional newspaper advertisement. All patients 
p a r t i c ip a t in g  in th is  s tu d y  u n d e r w e n t  a full phys ica l  
exam ina t ion  and  a s tan d a rd  neuro log ic  exam ina t ion  at 
the beginning of the study and, if indicated, further tech­
nical investigations. Patients with MS and healthy subjects 
were m atched  to the patients  with CFS in regard to age, 
sex, and educational level. The study was approved by the 
ethics com m ittee  of ou r  hospital and  patients  gave their 
informed consent.
INSTRUM ENTS
In a previous study, we developed a m ult id im ensional  fa­
tigue assessment m e th o d .1 In the present study, these di­
m ensions were m easured  by questionnaires  and  by a self­
observation list and  a Sleep Pattern Observation List over 
a 2-week period. For all ins trum ents ,  high scores indicate 
nonfavorable functioning.
Subjective Fatigue
Subjective fatigue was measured by the Subjective Fatigue sub­
scale of the Checklist of Individual Strength (CIS) .5 On the 
self-observation list, subjective fatigue was measured 4 times 
a day on a 4-point scale (Daily Observed Fatigue score).
Other Complaints
O ther  com plain ts  were assessed by the Com plain ts  Prob­
ing List, in which specific complaints were rated on a 4-point 
scale as follows: 1 , never present; 2 , several times a m onth ;
3, several times a week; and 4, every day.
Psychological Well-being
The Beck Depression Inventory (BDI) 15,16 is a standardized 
self-report questionnaire for measuring depression. Subjec­
tive fatigue was excluded as a symptom. The Symptom Check­
list (SCL) 17 is an indicator of psychological disturbances.
Impairment in Daily Life
The Sickness Impact Profile (SIP)181g measures the influence 
of complaints in different areas of daily functioning. On the 
self-observation list, patients indicated 4 times a day whether 
they had failed to perform activities as a result of fatigue.
Level of Physical Activity
The Physical Activities subscale of the CIS and the Mobil­
ity subscale of the SIP measure the level of physical activ­
ity. On the Physical Activities Rating Scale, patients indi­
c a te d  if th e y  h a d  e n g a g e d  in  2 0  d i f f e r e n t  a c t iv i t i e s  
( “n ev e r ,” “ra re ly ,” “no w  an d  th e n ,” “o f ten ,” and  “very 
o f t e n ”). O n  the se lf -obse rva t ion  list, level of physica l
Continued on next page
the Fatigue Severity Scale, do not provide a comprehen­
sive assessment of fatigue, as the subjective feeling of fa­
tigue is the only dimension measured.
In understanding fatigue in MS, patients with CFS 
may serve as a useful comparison group for 2 major rea­
sons: (1) fatigue is the key symptom in CFS and (2) there 
are indications that avoidance of physical activity, de­
pression, and cognitions and attributions can perpetu­
ate fatigue in CFS.6,7 Patients with CFS avoid physical ac­
tivity5 because in their view activity causes symptoms. 
This avoidant behavior in turn leads to more symptoms 
through physical deconditioning. Patients with CFS at­
tribute their symptoms to an organic cause and show a 
resistance to psychosocial interpretations of the com­
plaints. 5’8'10 Attributing complaints to an organic cause 
may reinforce the idea that physical activity is harmful. 
Depression may develop as a result of prolonged disabil­
ity and feelings of helplessness with respect to control­
ling complaints.b,y Since depressed patients have low lev­
els of physical activity, depression may contribute to the 
establishment of low levels of physical activity. Depres­
sion may also directly produce fatigue. In a longitudinal
study, we found that cognitions concerning subjective 
sense of control over symptoms are a powerful predic­
tor of fatigue and chronicity in CFS.11 It would be most 
valuable to investigate whether these psychological fac­
tors are involved in fatigue in MS as well.
In the present study, patients with MS were com­
pared with patients with CFS and healthy subjects to 
evaluate the status of the dimensions in MS and to evalu­
ate the relationships between the dimension of subjec­
tive fatigue and the other dimensions.
RESULTS
DEMOGRAPHICS
Information on age, sex, education, and duration of com­
plaints are summarized in Table 1 . There were no sig­
nificant differences between groups in these variables. There 
were also no significant differences in premorbid or cur­
rent occupational situations between patients with MS and 
patients with CFS (Table 2).  Compared with healthy sub­
jects, significantly more patients  with MS received
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activity was rated daily on a /-poin t  Likert scale (Daily O b ­
served Activity score).
Causal Attributions
Each patien t’s op in ions  concern ing  the causes of the co m ­
plaints were m easured  with  the Causal A ttr ibutions List. 
Eight possible causes of the complaints were presented. Pa­
tients could indicate on a 5-point Likert scale if they agreed 
or disagreed with each cause. There are 2 subscales: Physi­
cal and Psychosocial (Cronbach a  reliability coefficient was 
.71 and .75, respectively).
Sense of  C on tro l  Over Sym ptom s
The subjective sense of control over sym ptom s was m ea­
sured by a specific 5-point scale question (uDo you think you 
can influence your complaints?”) and selected items of the 
modified Pain Cognition List.20 The modification entails the 
replacement of the word pain by fatigue. The Cronbach a  
reliability coefficient for this scale was .74.
N europsycholog ica l  F unc t ion ing
The dimension of neuropsychological functioning was mea­
sured by the Concentration subscale of the CIS and the SIP.
Social F unc t ion ing
For social functioning, general questions were asked co n ­
cerning satisfaction in social life and problem s in social re­
lationships. The Social Interactions subscale of the SIP was 
also included.
Sleep D is tu rbances
On the self-observation list, quality of sleep ( “slept well,” 
“p ro b le m s  falling a s le e p ,” “res t less  s le e p ,” and  “early
aw aken ing  in the m o rn in g ”) was recorded  daily (Daily 
Observed Quality of Sleep scores). A special Sleep Pattern 
Observation List was completed in combination with the 
self-observation list. Retrospectively, the patient recorded 
daily every 30 m inutes  if resting or asleep. The following 
parameters were calculated over the 12-day period: hours 
asleep at night, hours asleep during  the day, hours awake 
before falling asleep, hours awake during the night, hours 
resting after waking up in the morning, and hours resting 
during  the day (Daily Observed Sleep Pattern score).
Information was collected concerning age, sex, educa­
tion, premorbid and current occupational situation, and d u ­
ration of complaints. Education level was detennined by a Dutch 
standardized scoring system (range, 1-7), which is especially 
applied in research. On the self-observation list, patients re­
ported once a day the hours spent on occupational activities.
DATA ANALYSIS
Logarithmic transformations were performed on variables 
with a skewness of more than 1. The analysis of differences 
between groups on nominal variables was carried out with 
the x : test and on ordinal variables with the M ann-W hitney 
test. In these tests, Bonferroni correction for multiple com ­
parisons was applied. Because there were 3 experimental 
groups, 3 comparisons were made. Assuming a significance 
level of .05, a difference was considered significant if the P 
value was less than .02. The analysis of differences between 
groups on ratio variables was performed by analysis of vari­
ance. Multiple com parisons were m ade by Duncan m u l­
tiple range tests. Unless stated otherwise, reported signifi­
cant differences refer to Duncan multiple range tests with a 
P value of less than .05. The relationship between subjec­
tive fatigue and other dimensions was evaluated by x 2 tests 
in the case of nominal and d ichotom ous variables. For other 
variables, the Pearson correlation coefficient was used. To 
control the type I error due to multiple correlations, only P 
values of less  than .01 were considered significant.
disablement insurance benefits (P< .001) ,  and signifi­
cantly more patients with CFS were on sick leave (P=.003) 
or received disablement insurance benefits (P<.001). Re­
sults of the self-observation list show that the patients with 
MS who indicated that they had been working worked an 
average of 2.7 d/wk (range, 0.5-4.5 dAvk) for 5.3 h/d (range, 
1-10 li/d). Patients with CFS who had jobs worked an av­
erage of 2.2 d/wk (range, 0.5-5 dAvk) for 4.1 h/d (range, 
1.5-11.5 h/d). Healthy subjects who had been working 
worked on average 3.2 d/wk (range, 0.5-6 d/wk) for 6.2 
li/d (range, 2-11 h/d). There was a significant difference 
between patients with CFS and healthy subjects with re­
spect to how many hours they worked per day (P=.001). 
In both patient groups, there was no relationship be­
tween subjective fatigue and any demographic variable.
DIMENSIONS
Subjective Fatigue and Other Complaints
Nineteen (39%) of the patients with MS reported fa­
tigue to be present several times a week (CFS, 13 [26%];
Table 1. Characteristics of 50 Patients With
Multiple Sclerosis (MS), 51 Patients With Chronic
Fatigue Syndrome (CFS) , and 53 Healthy Subjects
Characteristics MS CFS Healthy*
Sex, No. (%)
M 17(34) 12(24) 13(24)
F 33 (66) 39 (76) 40 (76)
Mean age (range), y 35.8 (19-56) :36.3 (19-54) 37.1 (19-63)
Mean education (range)f 3.6 (3-6) 4.2 (3-7) 4.3 (3-7)
Median duration of
complaints (range), y 5 (0.5-22) 5(1-48) • t •
* Ellipses indicate data not applicable.
t  Education level was determined according to a Dutch standardized 
scoring system (range, 1-7).
healthy, 8 [15%]), and 23 (46%) reported fatigue to be 
present every day (CFS, 38 [74%]; healthy, 0). Results 
on the Complaints Probing List (Table 3) show that there 
is a considerable overlap in symptoms between patients 
with MS and patients with CFS. Scores on the CIS Sub-
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Table 2. Occupational Situation Before Onset of 
Complaints and Current Occupational Situation of Patients 
With Multiple Sclerosis (MS), Patients With Chronic 
Fatigue Syndrome (CFS), and Healthy Subjects
Occupation
No. (%)
MS CFS
"  I
Healthy,
Current
i
Before
Onset
I
Current
i
Before
Onset
I
Current
Working 35 (70) 14 (28) 37 (72) 14 (27) 25 (47)
Housekeeping 0(0) 15(30) 0(0) 9(18) 14(26)
Unemployed 12(24) 3(6) 7(14) 3(6) 3(6)
Retired 0(0) 1(2) 0(0) 0(0) 2(4)
Disablement insurance
benefits 0(0) 11 (22) 0(0) 13(25) 0(0)
Sick leave 0(0) 5(10) 0(0) 10(20) 1(2)
School 3(6) 1(2) 7(14) 2(4) 8(15)
jective Fatigue subscale and the self-observation list are 
presented in Table 4. There were no differences in sub­
jective fatigue scores between patients with chronic pro­
gressive MS and patients with relapsing-remitting MS. To 
evaluate whether fluctuations in subjective fatigue se­
verity exist over time, separate subjective fatigue sever­
ity scores were calculated for week 1 and for week 2 on 
the self-observation list. The correlation between the 
scores for weeks 1 and 2 was r=0.89 in patients with MS 
and r=0.88 in patients with CFS. The mean difference 
in subjective fatigue severity between weeks 1 and 2 was 
4% for patients with MS, 3% for patients with CFS, and 
21% for healthy subjects. These results indicate that, in 
contrast to healthy subjects, patients with MS and pa­
tients with CFS experience little short-term fluctuation 
in subjective fatigue severity over time. The EDSS score 
was not related to subjective fatigue in MS.
Psychological Well-being
Results on the SCL are displayed in Figure 1 . Patients 
with MS had significantly lower scores than patients with 
CFS on the Somatization and Cognitive Difficulties sub­
scales. On all other subscales, both patient groups had 
similar scores. When compared with healthy subjects, pa­
tients with MS and patients with CFS did not have sig­
nificantly different scores on interpersonal sensitivity. On 
the other subscales, the patients in both groups had higher 
scores than did healthy subjects. The mean±SD BDI score 
was 10.0±6.5 for patients with MS and 10.8±4.7 for pa­
tients with CFS, which was not significantly different. The 
BDI score of healthy subjects was 2.7±3.7, which was 
significantly lower than the scores in the 2 patient groups. 
Using a BDI cutoff score of 16 or above, 17% of patients 
with MS, 16% of patients with CFS, but no healthy sub­
jects had current depression. Depression is thought to 
be a result of a prolonged disability or loss of sense of 
control over symptoms. However, in both patient groups, 
the BDI score was related only to the SIP Social Interac­
tions subscale (CFS, r=0.41; MS, r=0.68), not to any other 
measure of impairment in daily life, duration of com­
plaints, or sense of control. Depression is also hypoth-
Table 3. Prevalence of Complaints Based on the 
Complaints Probing List of Patients With Multiple 
Sclerosis (MS), Patients With Chronic Fatigue 
Syndrome (CFS), and Healthy Subjects*
Percentage P ( x2). 
----------------------- 1 MS and
Complaints MS CFS Healthy CFS
Fatigue 85+ 100+ 13 .01
Sleep problems 34 59+ 15 .03
Postexertional malaise 34+ 68+ 0 .003
Myalgia 39f 85+ 6 .001
Muscle weakness 49+ 69+ 2 .06
Headache 39+ 33+ 6 .60
Dizziness 15+ 41 + 0 .008
Memory problems 45+ 69+ 4 .03
Concentration problems 46+ 74+ 6 .01
Sore throat 3 18 4 .02
Tender lymph nodes 0 21 + 2 .002
Arthralgia 30 49+ 9 .04
Irritability 39+ 31 + 4 .44
Depressed mood 29+ 18 6 .23
* Complaints were rated present if they occurred at least several times a 
week.
f  Significant difference when compared with healthy subjects (?<.001 [ \ 2]).
tSignificant difference when compared with healthy subjects (P<.02 [ \ 2]).
esized to cause subjective fatigue directly or through pro­
ducing low levels of physical activity. No evidence was 
found for these associations in MS or CFS. In patients 
with MS and in patients with CFS, subjective fatigue se­
verity was only related to the Somatization subscale of 
the SCL (r=0.43 and r=0.48, respectively).
Im pairm ent in Daily Life
On the self-observation list, patients with MS reported 
less often than patients with CFS that they had failed to 
perform activities as a result of the complaints (Daily Ob­
servation Im pairm ent score, 46.0 and 23.9, respec­
tively; P=.001). Results on the SIP are displayed in 
Figure 2. Patients with MS had significantly lower scores 
than patients with CFS on the Activities at Home, Social 
Interactions, Concentration Problems, and Recreation and 
Pastimes subscales. On all subscales, patients with MS 
and patients with CFS had higher scores than healthy sub­
jects. In patients with MS and in patients with CFS, the 
CIS Subjective Fatigue subscale was related to Activities 
at Home (r=0.51 for both groups) and Recreation and 
Pastimes of the SIP (r=0.42 and r=0.44, respectively). 
On the self-observation list, the Daily Observed Fatigue 
score was related to the Daily Observed Impairment score 
in MS (r=0.40) and in CFS (r=0.63).
Level of Physical Activity
Results on physical activity are presented in Table 4. In 
CFS, evidence was found for the relationship between 
level of physical activity and physical attributions (physi­
cal attributions with Mobility of the SIP, r=0.35) and be­
tween subjective fatigue and physical activity: CIS Sub­
jective Fatigue with Mobility of the SIP (r=0.47), Physical 
Activity of the CIS (r=0.52), the Physical Activities Rat­
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Table 4. Results on Subjective Fatigue Severity, Physical Activity, and Neuropsychological Functioning 
of Patients With Multiple Sclerosis (MS), Patients With Chronic Fatigue Syndrome (CFS), and Healthy Subjects*
Variables MS CFS Healthy
Duncan Multiple Range Test
I
MS and 
CFS
MS and 
Healthy
I
CFS and 
Healthy
Subjective fatigue +
CIS 5.4±1.3 6.0±1.0 2.2+1.3 • • • • • •
Daily Observed Fatigue
OCO+lCDLO 7.9±2.4 1.6±1.4 • • • • • •
Physical activity
Daily Observed Activity 3.7±1.1 4.2±1.3 cn • l +
 
• O • • • • • •
Physical Activities Rating 3.7±0.4 3.9±0.4 2.8±0.5 .05 • • •
SIP, Mobility 5.3±8.2 7.5±8.7 0.2±1.5 .13 • • •
CIS, Activity 4.6±1.7 •
+ioo• 17.4±4.5 .65 •  •  •
Neuropsychological
CIS, Concentration 4.1 ±1.9 5.2±1.4 1.9±1.0 • • • •  •  •
SIP, Concentration 21.3± 18.9 35.0±18.7
CO
•
o+l• •  # • • • •
*CIS indicates Checklist Individual Strength (from Vercoulen et al5); SIP, Sickness Impact Profile (from Bergner et al18 and Jacob et al19); and ellipses, 
?<.05. Unless otherwise indicated, values are mean±SD.
ing List ( r=0 .35) ,  and the Daily Observed Activity 
(r=0.34). In MS, no such relationships were found.
Attributions Regarding the Causes
of the Complaints
The patients’ opinions concerning the causes of the com­
plaints are presented in Table 5. Of the patients with 
MS, 15 (30%) named at least 1 psychosocial cause, com­
pared with 7 (14%) of the patients with CFS (x2 test, 
P=.04). Forty-four (88%) of the patients with MS and 40 
(78%) of the patients with CFS named at least 1 physi­
cal cause, which was not significantly different. There were 
no significant differences between both patient groups 
in total scores regarding physical attributions and psy­
chosocial attributions. To evaluate whether there is a re­
sistance to psychosocial in terpretations of the com ­
plaints, correlations between psychosocial attributions 
and measures of psychological well-being (total scores 
on the BD1 and the SCL) were calculated. In CFS, there 
were no significant correlations between these vari­
ables. In MS, on the other hand, attributing complaints 
to psychosocial causes was related to high total scores 
on the BDI (r=0.52) and the SCL (r=0.64).
Sense of Control Over Symptoms
There were no significant differences in sense of control 
over symptoms between patients with MS and patients 
with CFS. Based on the sense of control question, 19 (38%) 
of the patients with MS and 12 (24%) of the patients with 
CFS were convinced that they could influence their com­
plaints. Sense of control was related to subjective fatigue 
severity in MS and in CFS (r=0.41 and ?'=0.38, respec­
tively).
Neuropsychological Functioning
In patients with MS, the prevalence of self-reported con­
centration problems was significantly lower than in pa­
tients with CFS (23 [46%] vs 38 [74%]), but there were
no significant differences in the prevalence of self- 
reported memory problems (22 [45%] vs 35 [69%]) 
(Table 3). In both patient groups, these prevalence rates 
were significantly higher than in healthy subjects. These 
findings were confirmed by results on the CIS and SIP 
Concentration subscales (Table 4). There was no rela­
tionship between subjective fatigue severity and memory 
and concentration problems on any instruments in MS 
or CFS.
Social Functioning
Eleven (21%) of the patients with MS reported difficul­
ties in social relationships (CFS, 13 [16%]; healthy, 10 
[19%]), and 5 patients (10%) (CFS, 9 [18%]; healthy, 5 
[9%] ) reported that they were dissatisfied with social func­
tioning. There were no significant differences in these vari­
ables between the 3 groups. On the Social Interactions 
subscale of the SIP (see “Impairment in Daily Life” sec­
tion), both patient groups had abnormal scores. There 
was no relationship between subjective fatigue and any 
social functioning variable in MS or CFS.
Sleep Problems
For self-reported prevalence rates of sleep problems see 
Table 3. There was no significant difference between pa­
tients with MS and patients with CFS in the SCL Sleep 
Disturbances subscale, but patients in both groups scored 
higher than healthy subjects (Figure 1). Results on the 
self-observation list on the Sleep Pattern Observation List 
are presented in Table 6. In both patient groups, sub­
jective fatigue was not related to any variable measuring 
aspects of sleep.
C O M M EN T
The main aims of the present study were to better char­
acterize fatigue in patients with MS and to investigate the 
relationships between the subjective experience of fa­
tigue and impairment in daily life, depression, level of
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ANX AGO DEP SOM COG SEN HOS SLP
Symptom
Figure 1. Symptom Checklist17 scores of patients with chronic fatigue 
syndrome (CFS), patients with multiple sclerosis (MS), and healthy 
subjects (H). Data were available on 35 healthy subjects. ANX indicates 
anxiety; AGO, agoraphobia; DEP, depression; SOM, somatization; COG, 
cognitive difficulties; SEN, interpersonal sensitivity; HOS, hostility; and 
SLP, sleep disturbances.
Area of Daily Functioning
Figure 2. Sickness Impact Profile scores of patients with chronic fatigue 
syndrome (CFS), patients with multiple sclerosis (MS), and healthy 
subjects (H). SR indicates sleep/rest; PC, personal caretaking; HM, 
activities at home; MOB, mobility; SI, social interactions; WLK, walking; 
CON, concentration; W, work; and RP, recreation and pastimes.
physical activity, cognitions and attributions, sleeping 
problems, and neuropsychological complaints.
The present study shows that fatigue in MS is a se­
rious problem. Almost half of the patients reported that 
they felt fatigued every day, and fatigue was present in 
85% of the patients at least once a week. Also, the pa­
tients with MS experienced high fatigue severity levels, 
almost as high as those of the patients with CFS. Fur­
thermore, in a 2 -week period, subjective fatigue sever­
ity was shown to be stable over time and was closely re­
lated to impairment in daily life.
Although problems in occupational situation were 
marked, which was most apparent from the substantial 
number of patients who were on sick leave or received 
disablement insurance benefits, occupational situation 
was not related to the level of subjective fatigue. This find­
ing might suggest that fatigue is not a problem that is se­
rious enough to cause a patient with MS to quit his or
Table 5. Patients’ Opinions Regarding
the Causes of the Complaints*
Percentage
Agreed
I I
Causes MS CFS P (x2)
Psychosocial
Work situation 2 4 .60
Home situation 4 0 .14
Life too busy 17 6 .09
Childhood 4 8 .44
Worry too much 33 4 .002
Physical
Virus 22 43 .03
Physical abnormalities 83 75 .28
Physical disease 82 49 .001
*MS indicates multiple sclerosis; CFS, chronic fatigue syndrome.
her job. However, in patients with CFS, the key symp­
tom of fatigue caused a similar percentage of patients to 
be on sick leave or to receive disablement insurance ben­
efits, and in this group there was also no relationship 
between the level of subjective fatigue and occupational 
situation.
With respect to the hypothesized role of psycho­
logical factors involved in the perpetuation of com ­
plaints, as outlined in the introduction, it can be con­
cluded that patients with MS and patients with CFS have 
similar profiles of depression, physical activity, sense of 
control over symptoms, and causal attributions. Regard­
ing the relationships between the relevant dimensions, 
several findings indicate similarities, but also differ­
ences, between patients with MS and patients with CFS 
with respect to the processes involved in the experience 
of fatigue.
First, sense of control appears to play an important 
role in subjective fatigue in CFS as well as in MS. In the 
present study, sense of control was closely related to sub­
jective fatigue in both patient groups. In a prospective study 
on the natural course in CFS, we found that a low sense 
of control was the strongest predictor of chronicity and a 
determinant of high subjective fatigue severity.11
Second, present data do not support the hypoth­
esized role of depression in fatigue in MS or CFS. No evi­
dence was found in either patient group for the hypoth­
esis that depression may develop as a result of prolonged 
disability or perceived helplessness in controlling com­
plaints. Also, the BD1 score was not related to subjective 
fatigue in MS or CFS.
Third, results with respect to the Somatization sub­
scale of the SCL are of interest. It has been shown that 
although there is psychological disturbance in patients 
with CFS, this in general is of only mild severity and is 
not as severe as in psychiatric patients .5,21,22 In the pres­
ent study, patients with MS and patients with CFS showed 
a similar profile on all measures of psychological well­
being, with the exception of the SCL Somatization sub­
scale. On this scale, patients with MS scored intermedi­
ately between healthy subjects and patients with CFS. In 
a previous study, we found that patients with CFS had 
som atization  scores similar to those of psychiatric
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Table 6. Results of Patients With Multiple Sclerosis (MS), Patients With Chronic Fatigue Syndrome (CFS), 
and Healthy Subjects (HS) on the Self-Observation List (Daily Observed Sleep Quality Scores) 
and Sleep Pattern Observation List (Daily Observed Sleep Pattern Scores)*
Duncan Multiple Range Testf
•
I
MS and MS and
I
CFS and
Criteria MS CFS Healthy CFS Healthy Healthy
Daily Observed Quality of Sleeps
Slept well 64±26.1 56±30.4 77 ± 15.5 .02 • • # • • •
Problems falling asleep 27±19.3 28±23.3 20±20.5 .49 .27 .83
Restless sleep 26±22.7 29±23.9 12±9.9 .76 .09 .05
Early awakening 21 ±24.1
COCsJ+ l 
CO 16±8.2 .27 • • l • • •
Daily Observed Sleep Pattern
Hours asleep at night 7.6±1.0 •
+ioCO ---J cn l +
 
o • .13 .99 .14
Hours awake before sleep
CO
•
o+lCO•
o
•
o+lCO0
o CO
•
o+l•
o
.11 .13 • • •
Hours awake during the night 0.4±0.4
LO
•
o+l•
o
0.1 ±0.1 .64 • •  • • • •
Hours staying in bed after sleep at night 0 • 1 + O
 
• 4^ 0
 
cn 1 +
 
o
 
• 4^ 0.3±0.3 .54 .27 .09
Hours asleep during the day 0 • 4^ 1 +
 
O cn 0.7±0.9 0.2±0.3 • • • • • • • • •
Hours rest during the day 0.5±0.5 1.1 ±1.2
CO
•
o+lCsJ•
CD
• • • • • • • • •
* Unless otherwise indicated, values are mean±SD. 
^Ellipses indicate P<.05.
$Mean percentage of occurrence.
outpatients.^ These results may indicate the presence of 
somatization disorder in CFS, which represents psycho­
logical disturbance expressed in multiple physical symp­
toms. In contrast to this hypothesis, we found that psy­
chological disturbance in patients with CFS, as measured 
with the other SCL subscales and the BDI, was moder­
ate and similar to that in patients with MS. In addition, 
other investigators have found the prevalence of soma­
tization disorder in patients with CFS to be quite low 
(15%)23,24 and similar to that in other patient groups.2>2/ 
Another interpretation of high somatization scores on the 
SCL may be that patients are highly tuned in to bodily 
sensations. Considering the close relationship between 
the SCL Somatization subscale and the CIS Subjective Fa­
tigue subscale in CFS as well as in MS, focusing on bodily 
sensations may play a role in the experience of fatigue 
in both patient groups. This process appears to be most 
pronounced in CFS.
Fourth, patients with CFS and patients with MS 
showed significantly lower levels of physical activity than 
healthy subjects. However, the level of physical activity 
was related to subjective fatigue and causal attributions 
in CFS but not in MS.
Finally, patients with MS and patients with CFS did not 
differ in total scores in regard to causal attributions. How­
ever, when the context in which such attributions are made 
is considered, it can be seen that there are differences between 
both groups. In MS, there is a somatic substrate, which gen­
erally is presented to the patient as “probably related to a vi­
ral infection.” In CFS, on the other hand, no somatic cause 
is established. Yet, the vast majority of patients with CFS 
named at least 1 physical cause and significantly more 
often than patients with MS indicated that a virus was re­
sponsible for their complaints. Furthermore, psychosocial 
attributions were more common in patients with MS than 
in patients with CFS, and these attributions were related to 
measures of psychological well-being in patients with MS 
but not in patients with CFS. These findings suggest that pa­
tients with MS are more open to psychosocial explanations
of the complaints than are patients with CFS, who show a 
strong resistance to this type of explanation, as has been docu­
mented previously.5,8'10 Causal attributions thus appear to 
play a different role in CFS than in MS.
In contrast to what was expected, EDSS scores were 
not related to subjective fatigue in MS. This finding sug­
gests that subjective fatigue in MS is not related to the 
disease activity.
Two methodological issues need to be addressed. First, 
in the MS sample, the majority of patients were only mildly 
affected as measured by the EDSS. It is unclear whether in 
more severely affected patients with MS fatigue would be 
even more severe or whether the relationships between sub­
jective fatigue and measures of the somatic substrate, physi­
cal activity, and attributions would yield different results. 
Second, in the present study, the EDSS was the only 
parameter reflecting somatic disturbance in MS. Future 
research should incoqDorate more explicit measures of the 
somatic substrate, notably magnetic resonance imaging.
Present findings indicate that fatigue is a serious 
problem in MS and provide a basis for future reasearch. 
A multidimensional approach proves to be a valuable 
method for assessing fatigue, not only to characterize fa­
tigue, but also to identify processes that may contribute 
to the subjective experience of fatigue. An important find­
ing of the present study is that psychological factors, such 
as sense of control and focusing on bodily sensations, seem 
to play a role in the subjective experience of fatigue in 
MS. At present, no effective somatic treatment for fa­
tigue exists. The recognition that psychological factors 
may be involved in the experience of fatigue opens pos­
sibilities for psychotherapeutic interventions.
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